Ancient herbs take on kidney disease: new trial begins

NCT ID NCT07657338

First seen Jun 19, 2026 · Last updated Jun 19, 2026

Summary

This pilot study tests whether adding a Chinese herbal formula called CKD-1 to standard care can improve kidney function in people with stage 3-4 non-diabetic chronic kidney disease. About 66 adults will be randomly assigned to receive either standard care alone or standard care plus the herbal formula for 12 weeks. Researchers will measure changes in kidney filtration rate, urine protein, and quality of life to see if the herbs offer any benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-DIABETIC CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • China Medical University Beigang Hospital

    Yunlin, Taiwan, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Chinese herbal formula CKD-1 (Astragalus, Salvia, Poria, Moutan, Scutellaria, Lonicera, Alisma)

What this could lead to

If it works, this could point toward a safe herbal add-on to help slow kidney decline in non-diabetic patients.

What could go wrong

This is a very small pilot study (66 people) with no blinding, so results may be unreliable. The herbal mix may not outperform standard care or could cause side effects.

Conditions

The condition(s) this trial relates to.

chronic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.